BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 31734639)

  • 21. Radiomics for the Prediction of Treatment Outcome and Survival in Patients With Colorectal Cancer: A Systematic Review.
    Staal FCR; van der Reijd DJ; Taghavi M; Lambregts DMJ; Beets-Tan RGH; Maas M
    Clin Colorectal Cancer; 2021 Mar; 20(1):52-71. PubMed ID: 33349519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: A meta-analysis.
    Ma Q; Li Z; Li W; Chen Q; Liu X; Feng W; Lei J
    Eur J Radiol; 2023 Nov; 168():111127. PubMed ID: 37801997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Textural radiomic features and time-intensity curve data analysis by dynamic contrast-enhanced MRI for early prediction of breast cancer therapy response: preliminary data.
    Fusco R; Granata V; Maio F; Sansone M; Petrillo A
    Eur Radiol Exp; 2020 Feb; 4(1):8. PubMed ID: 32026095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review.
    Di Re AM; Sun Y; Sundaresan P; Hau E; Toh JWT; Gee H; Or M; Haworth A
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):425-449. PubMed ID: 33289435
    [No Abstract]   [Full Text] [Related]  

  • 25. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The quality and clinical translation of radiomics studies based on MRI for predicting Ki-67 levels in patients with breast cancer.
    Wang M; Mei T; Gong Y
    Br J Radiol; 2023 Oct; 96(1150):20230172. PubMed ID: 37724784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence.
    Satake H; Ishigaki S; Ito R; Naganawa S
    Radiol Med; 2022 Jan; 127(1):39-56. PubMed ID: 34704213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma.
    Lin P; Liu WK; Li X; Wan D; Qin H; Li Q; Chen G; He Y; Yang H
    Clin Radiol; 2020 Jul; 75(7):561.e1-561.e11. PubMed ID: 32183997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer.
    Nemeth A; Chaudet P; Leporq B; Heudel PE; Barabas F; Tredan O; Treilleux I; Coulon A; Pilleul F; Beuf O
    MAGMA; 2021 Dec; 34(6):833-844. PubMed ID: 34255206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of background parenchymal enhancement on breast magnetic resonance imaging for pathological tumor response to neoadjuvant chemotherapy in breast cancers: a systematic review.
    Li X; Yan F
    Cancer Imaging; 2024 Mar; 24(1):35. PubMed ID: 38462607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of radiomics in magnetic resonance imaging for the pre-treatment characterisation of breast cancers: A scoping review.
    Campana A; Gandomkar Z; Giannotti N; Reed W
    J Med Radiat Sci; 2023 Dec; 70(4):462-478. PubMed ID: 37534540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
    Jia LL; Zheng QY; Tian JH; He DL; Zhao JX; Zhao LP; Huang G
    Front Oncol; 2022; 12():1026216. PubMed ID: 36313696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study.
    Granzier RWY; Ibrahim A; Primakov SP; Samiei S; van Nijnatten TJA; de Boer M; Heuts EM; Hulsmans FJ; Chatterjee A; Lambin P; Lobbes MBI; Woodruff HC; Smidt ML
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
    NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of radiomics in osteosarcoma: utilizing radiomics quality score as a tool promoting clinical translation.
    Zhong J; Hu Y; Si L; Jia G; Xing Y; Zhang H; Yao W
    Eur Radiol; 2021 Mar; 31(3):1526-1535. PubMed ID: 32876837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?
    Cai L; Sidey-Gibbons C; Nees J; Riedel F; Schäfgen B; Togawa R; Killinger K; Heil J; Pfob A; Golatta M
    Eur Radiol; 2024 Apr; 34(4):2560-2573. PubMed ID: 37707548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
    Li H; Yao L; Jin P; Hu L; Li X; Guo T; Yang K
    Breast; 2018 Aug; 40():106-115. PubMed ID: 29758503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
    Crombé A; Kind M; Ray-Coquard I; Isambert N; Chevreau C; André T; Lebbe C; Cesne AL; Bompas E; Piperno-Neumann S; Saada E; Bouhamama A; Blay JY; Italiano A;
    AJR Am J Roentgenol; 2020 Dec; 215(6):1539-1548. PubMed ID: 32991215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.